In addition, in combination with taxanes, sequential administration of CDK4/6 inhibitors prevented the proliferation of pancreatic ductal adenocarcinoma (PDAC) cells.7 This evidence concerns the gene CDK4 and pancreatic ductal adenocarcinoma.